Dragon Pharmaceutical Inc. (OTC BB: DRUG; TSX: DDD; BBSE: DRP) announces that it has retained the services of Renmark Financial Communications Inc. to handle its investor relations activities for investment brokers and advisors across the U.S. and Canada.
Renmark Financial will proactively articulate Dragon’s corporate messages and growth potential to professional investment brokers and advisors across U.S. and Canada. In addition, Dragon’s management team will also attend presentation sessions organized by Renmark Financials across North America to address the target audience upon the completion of the proposed acquisition of Oriental Wave.
“We are pleased to announce that we have selected Renmark to strengthen Dragon’s profile amongst the North American financial community. We will continue to participate in additional investor relations functions to increase the visibility of our company. We believe that Renmark Financial will be able to do so with its unique investor relations strategies and approach.” commented Dr. Alexander Wick, President and Chief Executive Officer of Dragon Pharmaceutical.
Get Dragon Pharma Steroids
668 total views, 1 today